http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111419920-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_091943d957040b52699f39835198d0da |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-738 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf4a46e7adc262f62ce3d69d9c56b7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee56ee3153bb664bd1ac701991e07de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cb05a38604742c8172df81eb68a1dba |
| publicationDate | 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111419920-A |
| titleOfInvention | Medicinal composition with hypoglycemic effect and preparation method and use thereof |
| abstract | The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition with hypoglycemic effect and a preparation method and application thereof. The technical problem to be solved by the present invention is to provide a brand-new pharmaceutical composition aimed at lowering blood sugar, which has a significant therapeutic effect on type 2 diabetes and an auxiliary therapeutic effect on type 1 diabetes. The pharmaceutical composition of the invention is prepared from the following raw materials by mass percentage: 5-50% of walnut shells, 5-50% of guava leaves, 5-50% of sweet tea leaves, 5-50% of masson pine bark, and 5-50% of apricot leaves. 60%, prickly pear root 10-70%, persimmon leaf 5-60%. The pharmaceutical composition of the invention can significantly reduce the fasting blood sugar of diabetic patients, has a significant therapeutic effect on type 2 diabetes, and has an auxiliary therapeutic effect on type 1 diabetes, providing a brand new choice for the public. |
| priorityDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.